The ExoDx Prostate Test provides a risk assessment for finding clinically significant prostate cancer that otherwise relies on biopsy in men with an elevated PSA.

What is the ExoDx™ Prostate Test? The ExoDx™ Prostate Test is a simple, non-DRE, urine-based, liquid biopsy test indicated for men 50 years of age and older with a prostate-specific …

The ExoDx Prostate Test is a non-invasive, non-DRE, urine test used as a risk assessment tool to provide risk probabilities for aggressive prostate cancer. It relies on cancer-specific genomic …

The ExoDx Prostate Test (EPI) provides actionable information that aids the prostate biopsy decision for men with PSA in the ‘gray zone’ of 2–10 ng/mL and is not dependent on other …

The ExoDx™ Prostate Test is a simple, non-DRE, urine-based, liquid biopsy test indicated for men 50 years of age and older with a prostate-specific antigen (PSA) 2-10ng/mL, or PSA in …

Answers about the ExoDx Prostate Test non-invasive urine test for Prostate Cancer. Learn about sensitivity of the EPI test, biomarkers analyzed, and interpretation of results.

Taking Charge of Your Prostate Health The ExoDx Prostate Test – A simple urine test to help inform the prostate biopsy decision.

The ExoDx(TM) Prostate Test or EPI (ExoDx Prostate Intelliscore Test) is a non-DRE urine-based liquid biomarker test indicated for men 50 years of age and older with a PSA 2–10 ng/mL …

If you are a patient working with your physician to assess prostate cancer risk, there are two ways to order the ExoDx Prostate Test: At-Home Collection or In-Office Collection.

ExoDx Prostate Test use resulted in a significant increase in patient compliance with the physician biopsy recommendations and demonstrated the following key points:4